** Brokerage Scotiabank upgrades life sciences tool maker
Waters Corp WAT.N rating to "sector outperform" from "sector
perform", raises PT to $450 from $430
** Brokerage says the rating is based on WAT's strong Q4
financial performance and 2025 profit forecast
** The price target is justified due to the timing of its
clients' instrument replacement cycles, significant revenue from
life science applications, and a leading position in emerging
markets such as GLP-1 obesity drugs and generic drugs in India -
Scotiabank
** "On the bottom line, WAT continues to have significant
EPS leverage, driven by its industry leading margins, recently
initiated productivity and pricing initiatives and cash
deployment capacity" - brokerage
** Stock rose 21.7% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))